Cumulative clinical and experimental evidence indicates that volatile sulphur compounds (VSC) the principal components of oral malodour, may play an important role in the pathogenesis of periodontal disease. As their (H₂S and CH₃SH) concentrations in gingival sulci increase with the severity of periodontal involvement, the objective of this investigation is to ascertain if they exert an effect on the permeability of oral mucosa. Permeability determinations were performed on excised porcine sublingual mucosal specimens which consisted of non-keratinized epithelium, basal membrane and connective tissue layers mounted in a two compartment perfusion apparatus. Using radioactive and fluorescent-labelled penetrants, it was found that exposure of the epithelial surface to an atmosphere containing physiological concentrations of both thiols (15 ng H₂S or CH₃SH / ml of 95% air - 5% C0₂) increased the permeability of the mucosa to (³⁵S)-S0₄⁻², (³H)-prostaglandin E₂ (PGE₂) and fluorescein isothiocyanate labelled E. coli lipopolysaccharide (F-LPS). A three hour exposure of the mucosa to H₂S and CH₃SH resulted in a 75% and 103% increase respectively in permeability to (³⁵S)-labelled sulphate ion. Similarly, the mercaptan induced up to a 70% increase in permeability of the mucosa to (³H)-prostaglandin E₂. The magnitude of changes in the permeability were found to depend on duration of exposure to the thiols and to their concentration. Studies using (³⁵S)-H₂S suggest that the observed changes in the tissue permeability are related to the reaction of the thiols with tissue components. In addition, the (³⁵S)-H₂S is capable of perfusing through all three layers of the mucosa at 12.3 ng / cm². In contrast to H₂S , the CH₃SH effect was irreversible in control air / C0₂ environment. This infers that CH₃SH is potentially a more deleterious agent to the tissue barrier. However, its effect can also be reversed by treatment of tissues with 0.22% ZnCl₂ either prior to or after exposure to mercaptan. This suggests that Zn⁺² ion may be useful in preventing the potentially harmful effects of VSC. Fluorescent studies with F-LPS indicate that thiols can also potentiate the penetration of endotoxin. Whereas the fluorescence of the F-LPS in control systems was confined to the superficial epithelial layer in contact with the endotoxin, the CH₃SH- exposed mucosa exhibited fluorescence throughout the epithelial and connective tissue layers. Fluorescent staining of the mucosal specimens with fluorescein diacetate followed by counter staining with ethidium bromide provides evidence of membrane impairment to some cells by CH₃SH. Collectively these observations provide strong experimental evidence that the VSC, products of putrefaction produced in the gingival sulcus by oral microflora, may adversely affect the integrity of the crevicular barrier to deleterious agents and thus contribute to the etiology of periodontal disease. / Dentistry, Faculty of / Graduate

abstract: Quiescin Sulfhydryl Oxidase 1 (QSOX1) generates disulfide bonds in its client substrates via oxidation of free thiols. Localized to the Golgi and secreted, QSOX1 helps to fold proteins into their active form. Early work with QSOX1 in cancer began with the identification of a peptide from the long form of QSOX1 in plasma from patients with pancreatic ductal adenocarcinoma. Subsequent work confirmed the overexpression of QSOX1 in numerous cancers in addition to pancreatic, including those originating in the breast, lung, brain, and kidney. For my work, I decided to answer the question, “How does inhibition of QSOX1 effect the cancer phenotype?” To answer this I sought to fulfill the following goals A) determine the overexpression parameters of QSOX1 in cancer, B) identify QSOX1 small molecule inhibitors and their effect on the cancer phenotype, and C) determine potential biological effects of QSOX1 in cancer. Antibodies raised against rQSOX1 or a peptide from QSOX1-L were used to probe cancer cells of various origins for QSOX1 expression. High-throughput screening was utilized to identify 3-methoxy-n-[4(1pyrrolidinyl)phenyl]benzamide (SBI-183) as a lead inhibitor of QSOX1 enzymatic activity. Characterization of SBI-183 activity on various tumor cell lines revealed inhibition of viability and invasion in vitro, and inhibition of growth, invasion, and metastasis in vivo, a phenotype that was consistent with QSOX1 shKnockdown cells. Subsequent work identified 3,4,5-trimethoxy-N-[4-(1-pyrrolidinyl)phenyl]benzamide (SPX-009) as an SBI-183 analog with stronger inhibition of QSOX1 enzymatic activity, resulting in a more potent reduction in tumor invasion in vitro. Additional work with QSOX1 shKnockdown and Knockout (KO) cell lines confirmed current literature that QSOX1 is biologically active in modulation of the ECM. These results provide evidence for the master regulatory role of QSOX1 in cancer, making it an attractive chemotherapeutic target. Additionally, the small molecules identified here may prove to be useful probes in further elucidation of QSOX1 tumor biology and biomarker discovery. / Dissertation/Thesis / Doctoral Dissertation Molecular and Cellular Biology 2020

京都大学 / 0048 / 新制・課程博士 / 博士(農学) / 甲第20431号 / 農博第2216号 / 新制||農||1048(附属図書館) / 学位論文||H29||N5052(農学部図書室) / 京都大学大学院農学研究科農学専攻 / (主査)教授 裏出 令子, 教授 松村 康生, 教授 三上 文三 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DFAM

No description available.

La quiescine/sulfhydryl oxydase QSOX1 catalyse la formation de ponts disulfures. In vivo, ses substrats et ses rôles cellulaires restent à déterminer. Les stress oxydants sont notamment impliqués dans les maladies neurodégénératives. L'hormone estradiol-17b (E2) possède des effets neuroprotecteurs. Nos objectifs ont été d'étudier la régulation de l'expression de QSOX1 par E2 et son implication dans les stress oxydants et la neuroprotection par E2.<br />Nous avons tenté d'établir un modèle de protection par E2 des cellules PC12/ERa soumises à un stress oxydant induit par H2O2 ou le complexe Fe(III)-HQ. Malgré différentes conditions testées, aucune protection par E2 n'a pu être obtenue.<br />Nous avons ensuite étudié la régulation de l'expression de QSOX1 dans le cerveau de Rates ovariectomisées traitées ou non par E2. Dans trois aires cérébrales exprimant fortement ERa et ERb, le niveau de messagers QSOX1 diminue en présence de E2.<br />Enfin, nous avons étudié l'implication de QSOX1 dans les stress oxydants. Dans les cellules PC12 soumises au stress oxydant, l'expression des messagers et de la protéine QSOX1 augmente. Suite au stress oxydant, la viabilité des cellules MCF-7 surexprimant QSOX1 diminue moins fortement que celle des cellules contrôles. La diminution de l'apoptose est associée à une moindre dépolarisation des mitochondries dans ces cellules.<br />Nos travaux ont ainsi permis de confirmer l'estrogéno-dépendance de QSOX1 in vivo et de montrer pour la première fois le rôle de QSOX1 dans la protection des cellules contre l'apoptose induite par les stress oxydants. Ces résultats ouvrent de nouvelles perspectives et renforcent l'intérêt de l'étude de QSOX1 dans la neuroprotection par E2.

None.

Made available in DSpace on 2016-08-17T17:39:01Z (GMT). No. of bitstreams: 1 DISSERTACAO_ELYJANY MORAIS LIMA SENA.pdf: 1561186 bytes, checksum: 888156a1b9f61af2c114710a272cf739 (MD5) Previous issue date: 2014-10-17 / Conselho Nacional de Desenvolvimento Científico e Tecnológico / Protein disulfide isomerase (PDI) plays an important role in platelet aggregation involving thiol containing surface proteins in both dependent pathways and independent of ADP. Recently it has been shown that one dodecapeptide (CXXC) containing the catalytic motif PDI was able to decrease the reductase activity of PDI opening the perspective of using the same as antithrombotic therapeutic agent. This study aimed to investigate the effects of peptides PDI - like on platelet aggregation in vitro and molecular mechanism of action of the same. For in silico analysis using a molecular docking program, it was observed that the CXXC peptide as well as its control peptide, scrambled (SCR) and AXXA were all capable of binding to the substrate site of the lligação PDI. Posteriorly, Western blot, it was demonstrated that the peptide CXXC (25  M) induced a slight but significant reduction of free thiols marking PDI suggesting physical association between the peptide and the protein. The same was not observed in samples incubated with Scr and AXXA peptides at the same concentration. In platelet aggregation assays, the platelet-rich plasma (PRP) was pre-incubated with the CXXC, Scr and AXXA peptides using ADP (5  M) as aggregating agent. CXXC found that the peptide reduced the maximum aggregation by 14%, 27% and 30% at concentrations of 3, 10 and 30μM, respectively. The Scr AXXA peptide and the peptide had no effect on platelet aggregation induced by ADP in the same concentrations. Thus, all the data presented here suggest that the CXXC peptide is associated with PDI surface and partially inhibits platelet aggregation via mechanisms mediated by thiol-disulfide exchange. / A Proteína dissulfeto isomerase (PDI) desempenha um importante papel na agregação de plaquetas, envolvendo proteínas tiólicas de superfície tanto em vias dependentes, quanto independentes de ADP. Recentemente foi demostrado que um dodecapeptídeo (CxxC), contendo o motivo catalítico da PDI, era capaz de diminuir a atividade redutase da PDI, abrindo a perspectiva do uso do mesmo como agente terapêutico antitrombótico. Assim, este trabalho teve como objetivo investigar os efeitos de peptídeos PDI símile sobre a agregação plaquetária in vitro e o mecanismo molecular de ação dos mesmos. Por análises in silico utilizando um programa de ancoragem molecular, observou-se que o peptídeo CxxC, bem como os seus peptídeos controle, scrambled (Scr) e AxxA, foram todos capazes de se ligar ao sítio de lligação do substrato na PDI. Posteriomente, por western blot ,demonstrou-se que o peptídeo CxxC (25 M) promoveu uma discreta, mas importante, redução da marcação de tióis livres da PDI sugerindo associação física entre o peptídeo e a proteína. O mesmo não foi observado nas amostras incubadas com os peptídeos Scr e AxxA, na mesma concentração. Nos ensaios de agregação plaquetária, o plasma rico em plaquetas (PRP) foi pré-incubado com os peptídeos CxxC, Scr e AxxA utilizando ADP (5M) como agente agregante. Encontramos que o peptídeo CxxC reduziu a agregação máxima em 14%, 27% e 30% nas concentrações de 3, 10 e 30μM, respectivamente. O peptídeo Scr e o peptídeo AxxA, não afetaram a agregação plaquetária induzida por ADP nas mesmas concentrações. Sendo assim, o conjunto dos dados aqui apresentados sugerem que o peptídeo CxxC associa-se à PDI de superfície e inibe parcialmente a agregação plaquetária via mecanismos mediados por trocas tiol-dissulfeto.

The lumen-to-cell transport, cellular accumulation, and toxicity of ionic cadmium (109Cd2+) and cadmium-cysteine conjugate (Cys-S-109Cd-S-Cys) were studied in isolated perfused S2 segments of the proximal tubule of the rabbit kidney. All perfusion solutions were HEPES buffered and contained 3H-L-glucose which functioned as a volume and leak marker along with 250 nM FD & C Green dye as a vital dye. When ionic cadmium, 0.73µM Cd2+, or 0.73µM cadmium-cysteine conjugate (Cys-S-109Cd-S-Cys) containing solution was perfused through the lumen of the tubule there was no visual evidence of toxicity such as blebbing of the luminal membrane, cellular vital dye uptake, and cellular swelling. Ionic Cd2+ transport was temperature dependent (87% reduction at 22°C and 100% at 11°C) and inhibited by FeCl2 (42% reduction at 10µM) and ZnCl2 (48% reduction at 20µM), and high Ca2+ concentrations (27% reduction at 1.95mM and 69% at 2.6mM). The ionic Cd2+ transport was not affected by verapamil and diltiazem. The cadmium conjugate (Cys-S-Cd-S-Cys) transport was also temperature dependent (76% reduction at 22°C and 100% at 11°C) and inhibited by the amino acids L-cystine and L-arginine (55% and 50% respectively), stimulated by L-methionine (56%), but not affected by L-aspartate, L-glutamate and Gly-Sar. 2, 3-Dimercaptopropane-1-Sulfonate (DMPS) co-perfused with Cd2+ decreased absorption of 20µM Cd2+ (39% reduction at 30 µM and 94.6% reduction at 200 µM), while DMPS added to the bathing solution has no effect on the luminal transport of Cd2+. DMPS co-perfused with 20 µM Cys-S-Cd-S-Cys substantially reduced Cd2+ transport (62% reduction at 30 µM). We conclude that cadmium can be transported at the luminal membrane of the S2 segment of the proximal tubule by multiple mechanisms, depending on the form which it is presented to membrane. Ionic cadmium appears to be transported by iron (DCT1), zinc (ZTL1) transporters and some kind of calcium-selective channel while cadmium conjugate of L-cysteine appears to be transported by L-cystine transporters (system b0+). Dipeptide transporter is not involved in the transport of cadmium. DMPS appears to be a chelator for cadmium.

Fundação de Amparo a Pesquisa no Estado do Rio Grande do Sul / The compound 2,2 -dithienyl diselenide (DTDS), an organoselenium compound with thiophene moieties, has been proven to be a promising antioxidant in vitro and in vivo, as well as an antifungal and antimicrobial agent. However, its toxicity, an important point to be investigated, has not been evaluated. The objective of this study was to evaluate whether DTDS has potential toxicity in vitro or in vivo. For this reason, sulfhydryl enzyme activities, such as δ-aminolevulinic acid dehydratase (δ-ALA-D) and Na+, K+-ATPase were assessed to predict in vitro DTDS toxicity in rat brain homogenate, in addition to its thiol oxidase-like activity. In other section of experiments, DTDS was administered to rats (50 or 100 mg/kg; per orally) in order to determine toxicological parameters in vivo. Plasma samples were collected in order to measure the biochemical parameters: alanine (ALT) and aspartate (AST) aminotransferase activities and urea and creatinine levels. Besides, in brain homogenates, it was determined the activity of the enzymes δ-ALA-D and Na+, K+-ATPase, as well as lipid peroxidation levels and antioxidant defenses (catalase and superoxide dismutase activities and ascorbic acid and reduced glutathione levels). The compound DTDS inhibited in vitro both δ-ALA-D and Na+, K+-ATPase activities (IC50 2 μM and 17 μM, respectively). The DTDS inhibitory effect on δ-ALA-D and Na+, K+-ATPase activities was restored by dithiol dithiothreitol. In addition, DTDS (5-25 μM) showed a thiol oxidase-like activity. In vivo, DTDS (50 and 100 mg/kg) caused a decrease in food and water intakes and the loss of body weight, indicating systemic toxicity, even causing death of the animals. At a dose of 100 mg/kg, DTDS decreased urea levels and increased plasma alanine and aspartate aminotransferase activities. Lipid peroxidation was increased in both administered doses. Moreover, in the highest dose, DTDS inhibited δ-ALA-D activity. By contrast, neither Na+, K+-ATPase activity nor antioxidant defenses were altered in the brain of rats exposed to DTDS. In conclusion, the interaction with thiol groups of sulfhydryl enzymes seems to mediate the inhibitory effect of DTDS against δ-ALA-D and Na+, K+-ATPase activities in vitro. Furthermore, in the administered doses, DTDS causes cerebral and systemic toxicity in rats. Although other studies are necessary to give more information about this specific compound, our findings contribute to the knowledge on the toxicology of DTDS, a compound with pharmacological properties. / O composto 2,2 -disseleneto de ditienila (DSDT), um composto orgânico de selênio com grupamento tiofeno, fora comprovado como um promissor antioxidante in vitro e in vivo, assim como um agente antifúngico e antimicrobiano. Entretanto, sua toxicidade ainda não fora avaliada, representando um importante ponto a ser investigado. O objetivo deste estudo foi avaliar se o DSDT apresenta potencial toxicidade in vitro ou in vivo. Para este fim, a atividade de enzimas sulfidrílicas, como δ-aminolevulato desidratase (δ-ALA-D) e Na+, K+-ATPase fora testada para predizer a toxicidade in vitro do DSDT em homogeneizado de cérebro de ratos, bem como a sua atividade tipo-tiol oxidase. Em outra seção de experimentos, o DSDT foi administrado em ratos (50 ou 100 mg/kg; oralmente) com o intuito de determinar parâmetros toxicológicos in vivo. Amostras de plasma foram retiradas para dosagem dos parâmetros bioquímicos: atividade das enzimas alanina (ALT) e aspartato (AST) aminotrasferase e níveis de ureia e creatinina. Além disso, em homogeneizado de cérebro foram dosadas a atividade das enzimas δ-ALA-D e Na+, K+-ATPase, assim como os níveis de peroxidação lipídica e as defesas antioxidantes (atividade das enzimas catalase e superóxido dismutase e níveis de ácido ascórbico e glutationa reduzida). O composto DSDT inibiu in vitro, tanto a atividade da δ-ALA-D quanto da Na+, K+-ATPase (IC50 2μM e 17μM, respectivamente). O efeito inibitório do DSDT sobre a atividade das enzimas δ-ALA-D e Na+, K+-ATPase foi restaurado pelo ditiol ditiotreitol. Adicionalmente, DSDT (5-25μM) apresentou atividade do tipo-tiol oxidase. In vivo, o DSDT (50 e 100 mg/kg) causou uma diminuição no consumo de comida e água e perda de peso corporal, evidenciando toxicidade sistêmica, causando inclusive morte de ratos. Quando administrado na dose de 100 mg/kg, DSDT diminui os níveis de ureia e aumentou a atividade plasmática da ALT e da AST. Os níveis de peroxidação lipídica encontraram-se aumentados em ambas as doses administradas. Na maior dose, o DSDT inibiu a atividade da δ-ALA-D. Em contrapartida, nem a atividade da Na+, K+-ATPase nem as defesas antioxidantes foram alteradas no cérebro de ratos expostos ao DSDT. Em conclusão, a interação com grupos tióis de enzimas sulfidrílicas parece mediar o efeito inibitório do DSDT em relação a atividade da δ-ALA-D e da Na+, K+-ATPase in vitro. Além disso, nas doses administradas, o DSDT induz toxicidade cerebral e sistêmica em ratos. Embora outros estudos sejam necessários para fornecer mais informações sobre este composto em específico, estes dados contribuem para o conhecimento sobre a toxicologia do DSDT, um composto com propriedades farmacológicas.

Made available in DSpace on 2015-07-22T20:49:20Z (GMT). No. of bitstreams: 0 Previous issue date: 2012-02-29. Added 1 bitstream(s) on 2015-08-11T03:26:18Z : No. of bitstreams: 1 Publico-13280.pdf: 1828173 bytes, checksum: df8fb9928c37e920c5f9a2281ba9c092 (MD5) / O presente trabalho trata do estudo conformacional de S-nitrosotióis com potencial atividade biológica, 2–acetamido-3-metil-3-nitrosossulfanil-N-arilbutanamidas, e de seus tióis precursores, 2–acetamido-3-mercapto-3-metil-N-arilbutanamidas. As conformações de menor energia dos S-nitrosotióis e tióis em estudo são estabilizadas por ligações de hidrogênio intramoleculares que promovem uma maior estabilidade dos confôrmeros. A análise geométrica do grupo R-SNO mostra que esses compostos preferem a conformação trans. O cálculo das interações orbitalares pelo método NBO (Natural Bond Orbital) para as 2–acetamido-3-mercapto-3-metil-N-arilbutanamidas mostrou que as mesmas são estabilizadas pelas seguintes interações: no (N2) → &#61552;&#61482; (C3-O4) e no(N10) → (C11-O12). Os resultados de NBO para os S-nitrosotíois mostraram que a interação hiperconjugativa é bastante efetiva nas conformações estáveis desses compostos, enfraquecendo a ligação que resulta no aumento do comprimento da ligação S-N em S-Nitrosotióis. A forte delocalização , induz caráter parcial a ligação S-N. A fraca ligação S-N indica uma forte delocalização do par de elétrons do O(NO) devido a interação, que é responsável pelo alongamento da ligação S-N, aumentando e a potencial capacidade do óxido nítrico ser liberado. / We carried out a conformational study on the S-nitrosothiols (R-SNO), 2-acetamido-3-methyl-3-(nitrososulfanyl)-N-arylbutanamides and their thiol precursors 2-acetamido-3-mercapto-3-methyl-N-arylbutanamides. The lowest energy conformation for both compounds is stabilized by intramolecular hydrogen bonds. Trans conformation was determined as the predominant conformation after geometrical analysis of R-SNO. Orbital interactions for 2-acetamido-3-mercapto-3-methyl-N-arylbutanamides were calculated using Natural Bond Orbital (NBO) methodology. Calculations indicated that orbital interactions for these compounds are stabilized by the following interactions: no (N2) → &#61552;&#61482; (C3-O4) and no(N10) → (C11-O12). NBO results showed that the hyperconjugative interaction is very effective, weakening the σ bond and resulting in increasing length of the S-N bond in R-SNO. The strong delocalization induces partial character to the S-N bond. The bond S-N indicates a strong delocalization of the electron pair of O(NO) due to interaction. This interaction is responsible for the elongation of the S-N bond which increases the ability of the compound to release nitric oxide (NO). Based on the enhanced capacity to release NO by these compounds, our findings suggest that both compounds may display biological activity. / TEDE / BV UNIFESP: Teses e dissertações